ADC Therapeutics SA (NYSE:ADCT)
| 3.37 Delayed Data As of Nov 29 |  -0.01 / -0.30%Today’s Change | 3.31 Today|||52-Week Range 23.28 | -83.32% Year-to-Date |
Latest ADCT News | Press Releases
No recent news for ADC Therapeutics SA.
Today’s Trading
| Previous close | 3.38 |
| Today’s open | 3.35 |
| Day’s range | 3.35 - 3.43 |
| Volume | 325,581 |
| Average volume (3 months) | 323,007 |
| Market cap | $276.9M |
Data as of 3:59pm ET, 11/29/2022
Growth & Valuation
| Earnings growth (last year) | +20.40% |
| Earnings growth (this year) | +23.17% |
| Earnings growth (next 5 years) | +9.69% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 45.71 |
| Price/Book | 1.66 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 16, 2023 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $33.9M |
| Annual profit (last year) | -$230.0M |
| Net profit margin | -678.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
